| 11th Apr 2018 4:41 pm |
RNS |
Stmnt re Share Price Movement |
| 2nd Mar 2018 1:30 pm |
RNS |
Update re: Broker |
| 27th Feb 2018 9:37 am |
RNS |
Holding(s) in Company |
| 31st Jan 2018 7:00 am |
RNS |
NXP002 Pilot Study in Lung and Liver Fibrosis |
| 15th Dec 2017 7:30 am |
RNS |
Agreement to License NXP001 |
| 14th Dec 2017 7:00 am |
RNS |
Dr Andy Richards Chairs Advisory Panel - New Appts |
| 12th Dec 2017 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 12th Dec 2017 4:35 pm |
RNS |
Price Monitoring Extension |
| 6th Dec 2017 7:00 am |
RNS |
Grant of Warrants |
| 1st Dec 2017 7:30 am |
RNS |
Appointment of Broker |
| 10th Nov 2017 10:19 am |
RNS |
Holding(s) in Company |
| 1st Nov 2017 12:23 pm |
RNS |
Holding(s) in Company |
| 23rd Oct 2017 7:30 am |
RNS |
Holding(s) in Company |
| 19th Oct 2017 7:00 am |
RNS |
NXP001 agreement for pilot bioequivalence study |
| 16th Oct 2017 7:00 am |
RNS |
Admission and First Dealings |
| 16th Oct 2017 7:00 am |
RNS |
Cancellation Notice and Re-Admission |
| 13th Oct 2017 3:44 pm |
RNS |
Change of Name |
| 13th Oct 2017 12:35 pm |
RNS |
Result of Meeting and Completion of Acquisition |
| 13th Oct 2017 7:00 am |
RNS |
Half-year Report |
| 22nd Sep 2017 7:00 am |
RNS |
Final Results and Annual Report |
| 15th Sep 2017 2:15 pm |
RNS |
Prospectus re: Proposed Acquisition of Nuformix |
| 20th Apr 2017 7:00 am |
RNS |
Convertible Loan Agreement |
| 23rd Dec 2016 7:00 am |
RNS |
Half-year Report |
| 21st Sep 2016 7:00 am |
RNS |
Accounts for the period ended 31 March 2016 |
| 21st Sep 2016 7:00 am |
RNS |
New Accounting Ref Date |
| 16th Sep 2016 1:03 pm |
RNS |
Possible Acquisition and Suspension of Trading |
| 29th Mar 2016 7:00 am |
RNS |
Half Yearly Report |
| 24th Feb 2016 7:00 am |
RNS |
Broker Appointment and Corporate Update |
| 17th Dec 2015 7:00 am |
RNS |
Publication of Prospectus and First Dealings |
